Table 1

Patients treated with the different cisplatin-based chemotherapy regimens for the entire cohort (n = 83) and those patients assessed and stratified according to response to chemotherapy (n = 71)

Type of chemotherapyChemo-sensitive subgroup (n = 33)Chemoresistant subgroup (n = 38)No. of patients in entire cohort (n = 83)
Cisplatin and methotrexate10820
Cisplatin, methotrexate, and vinblastine10720
Cisplatin, methotrexate, and epirubicin102037